why choose us

First received: June 14, 2024

Clinical Trial: Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hereditary Angioedema

Study Type: INTERVENTIONAL


Official Title: Open-Label Safety, Pharmacokinetic, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With Hereditary Angioedema Type I or II

Brief Summary: KVD900-303 is an open-label, multicenter clinical trial in patients aged 2 to 11 years old with HAE Type I or II.

Read more